- 暂无数据
简体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, Liang Xu's team from the Laser Center of Anguang Institute, Chinese Academy of Sciences, Hefei Institute of Materia Medica, conducted research on corona discharge fluid control and its application in the gas laser system, proposed an electric field flow field coupling analysis model suitable for multi pin corona discharge scenarios, and revealed the flow velocity distribution characteris...
Abstract: A groundbreaking discovery by CNR Nanotec and scientists from the University of Warsaw has revealed a robust method for creating long-lived quantum fluids using semiconductor photonic gratings. This study, published in the journal Nature Physics, marks a significant step forward in simulating complex systems through unique polariton droplets that demonstrate stability in lifespan and rec...
Optical equipment is an integral part of technologies such as data centers and autonomous vehicle, which are constantly developing to meet the needs of complex applications. The challenge faced by designers is to manipulate light at the wavelength scale to achieve the required optical properties, which requires precision at both the nano and macro scales. Nanoscale structures, such as those on LED...
German laser Fusion developer Marvel Fusion said it will partner with Colorado State University (CSU) on a new $150 million laser equipment lab to study inertial fusion energy and high energy density physics."It will be home to one of the most powerful laser facilities in the world and an international center for laser fusion energy and high energy density physics research," the company said in a ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...